KYTX
Kyverna Therapeutics Inc.
$8.78
+$0.42(+5.02%)
54
Overall
60
Value
63
Tech
39
Quality
Market Cap
$299.26M
Volume
1.10M
52W Range
$1.78 - $9.75
Target Price
$25.25
Key Metrics Overview
| Market Cap | $299.26M | P/E Ratio | N/A |
| 52W High | $9.75 | 52W Low | $1.78 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | 77.1% | 52W Position | 87.8% |
| Overall Score | 54 | Value Score | 60 |
| Quality Score | 39 | Technical Score | 63 |
Growth Analysis
| EPS Current Est | $-3.7 | EPS Next Est | $-3.63 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KYTX | $8.78 | +5.0% | 1.10M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Kyverna Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW